Measurement of Small Molecule Binding Kinetics on a Protein Microarray by Plasmonic-Based Electrochemical Impedance Imaging

被引:44
作者
Liang, Wenbin [1 ,3 ]
Wang, Shaopeng [1 ]
Festa, Fernanda [2 ]
Wiktor, Peter [1 ]
Wang, Wei [1 ]
Magee, Mitchell [2 ]
LaBaer, Joshua [2 ]
Tao, Nongjian [1 ,4 ]
机构
[1] Arizona State Univ, Ctr Bioelect & Biosensors, Biodesign Inst, Tempe, AZ 85287 USA
[2] Arizona State Univ, Ctr Personalized Med, Biodesign Inst, Tempe, AZ 85287 USA
[3] Third Mil Med Univ, Dept Clin Biochem, Lab Sci, Chongqing 400038, Peoples R China
[4] Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA
关键词
CRYSTAL-STRUCTURE; TYROSINE KINASE; ABL; INHIBITION; COMPLEX; ARRAYS;
D O I
10.1021/ac5024556
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We report on a quantitative study of small molecule binding kinetics on protein microarrays with plasmonic-based electrochemical impedance microscopy (P-EIM). P-EIM measures electrical impedance optically with high spatial resolution by converting a surface charge change to a surface plasmon resonance (SPR) image intensity change, and the signal is not scaled to the mass of the analyte. Using P-EIM, we measured binding kinetics and affinity between small molecule drugs (imatinib and SB202190) and their target proteins (kinases Abl1 and p38-alpha). The measured affinity values are consistent with reported values measured by an indirect competitive binding assay. We also found that SB202190 has weak bindings to ABL1 with K-D > 10 mu M, which is not reported in the literature. Furthermore, we found that P-EIM is less prone to nonspecific binding, a long-standing issue in SPR. Our results show that P-EIM is a novel method for high-throughput measurement of small molecule binding kinetics and affinity, which is critical to the understanding of small molecules in biological systems and discovery of small molecule drugs.
引用
收藏
页码:9860 / 9865
页数:6
相关论文
共 41 条
[1]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[2]   Nucleotide binding by the histidine kinase CheA [J].
Bilwes, AM ;
Quezada, CM ;
Croal, LR ;
Crane, BR ;
Simon, MI .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (04) :353-360
[3]   Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology [J].
Cannon, MJ ;
Papalia, GA ;
Navratilova, I ;
Fisher, RJ ;
Roberts, LR ;
Worthy, KM ;
Stephen, AG ;
Marchesini, GR ;
Collins, EJ ;
Casper, D ;
Qiu, HW ;
Satpaev, D ;
Liparoto, SF ;
Rice, DA ;
Gorshkova, II ;
Darling, RJ ;
Bennett, DB ;
Sekar, M ;
Hommema, E ;
Liang, AM ;
Day, ES ;
Inman, J ;
Karlicek, SM ;
Ullrich, SJ ;
Hodges, D ;
Chu, T ;
Sullivan, E ;
Simpson, J ;
Rafique, A ;
Luginbühl, B ;
Westin, SN ;
Bynum, M ;
Cachia, P ;
Li, YJ ;
Kao, D ;
Neurauter, A ;
Wong, M ;
Swanson, M ;
Myszka, DG .
ANALYTICAL BIOCHEMISTRY, 2004, 330 (01) :98-113
[4]   Electrochemical Impedance Spectroscopy [J].
Chang, Byoung-Yong ;
Park, Su-Moon .
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 3, 2010, 3 :207-229
[5]   Label-free screening of bio-molecular interactions [J].
Cooper, MA .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2003, 377 (05) :834-842
[6]   Protein kinase C θ (PKCθ) expression and constitutive activation in gastrointestinal stromal tumors (GISTs) [J].
Duensing, A ;
Joseph, NE ;
Medeiros, F ;
Smith, F ;
Hornick, JL ;
Heinrich, MC ;
Corless, CL ;
Demetri, GD ;
Fletcher, CDM ;
Fletcher, JA .
CANCER RESEARCH, 2004, 64 (15) :5127-5131
[7]   A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336
[8]   Surface impedance imaging technique [J].
Foley, Kyle J. ;
Shan, Xiaonan ;
Tao, N. J. .
ANALYTICAL CHEMISTRY, 2008, 80 (13) :5146-5151
[9]   BCR-ABL in chronic myelogenous leukemia - How does it work? [J].
Goldman, John M. ;
Melo, Junia V. .
ACTA HAEMATOLOGICA, 2008, 119 (04) :212-217
[10]   Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].
Heinrich, MC ;
Griffith, DJ ;
Druker, BJ ;
Wait, CL ;
Ott, KA ;
Zigler, AJ .
BLOOD, 2000, 96 (03) :925-932